GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Scotia Capital Inc.

Scotia Capital Inc. raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,781 shares of the company’s stock after purchasing an additional 828 shares during the period. Scotia Capital Inc.’s holdings in GE HealthCare Technologies were worth $1,312,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in GEHC. CoreFirst Bank & Trust acquired a new stake in GE HealthCare Technologies in the fourth quarter worth about $25,000. Runnymede Capital Advisors Inc. acquired a new stake in GE HealthCare Technologies in the 4th quarter worth approximately $28,000. Bank of Jackson Hole Trust purchased a new stake in GE HealthCare Technologies during the 4th quarter worth approximately $32,000. OFI Invest Asset Management acquired a new position in GE HealthCare Technologies during the 4th quarter valued at approximately $34,000. Finally, Flagship Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies in the fourth quarter worth $34,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC opened at $62.81 on Monday. The firm has a fifty day moving average price of $81.75 and a 200 day moving average price of $84.00. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The stock has a market cap of $28.72 billion, a P/E ratio of 14.51, a P/E/G ratio of 3.19 and a beta of 1.14. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.22%. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of a number of research analyst reports. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $97.73.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.